GWAS 2023-01-01

Axelsen TM, Bager C et al.

J Prev Alzheimers Dis

Disease modifying treatments for dementia are only just surfacing, and their development is still si...

Serum Tau-A levels

4968

Participants

N/A

Studies

GWAS 2022-01-01

Schneider LS, Laudon M et al.

J Prev Alzheimers Dis

Piromelatine is a novel melatonin MT1/2/3 and serotonin 5-HT-1A/1D receptors agonist developed for m...

Response to piromelatine in mild Alzheimer's disease

107

Participants

N/A

Studies

Title

Author

Journal

Disease/Trait

Date

Actions

Axelsen TM, Bager C et al.

J Prev Alzheimers Dis

Serum Tau-A levels

2023-01-01

Schneider LS, Laudon M et al.

J Prev Alzheimers Dis

Response to piromelatine in mild Alzheimer's disease

2022-01-01